International Journal-Cancer Hoboken, NJ - 07030

International Journal-Cancer is categorized under Periodical Publishers in Hoboken, NJ .

International Journal-Cancer was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Periodical Publishers business, which does work in the B2B market, and is classified as a Periodical Publishers, under code number 5111200 by the NAICS.

If you are seeking more information, feel free to contact Sherryl Sundell, Manager at the company’s single location by writing to 111 River St, Hoboken, New Jersey NJ 07030 or by phoning (201) 748-8832. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: International Journal-Cancer
Contact Person: Sherryl Sundell, Manager
Address: 111 River St, Hoboken, New Jersey 07030
Phone Number: (201) 748-8832
Website Address: wiley.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Periodical Publishers
SIC Code: 2721
NAICS Code: 5111200
Share This Business:

International Journal-Cancer was started in 0 to provide professional Periodical Publishers under the SIC code 2721 and NAICS code 5111200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Sherryl Sundell, Manager for inquiries that concern International Journal-Cancer by calling the company number (201) 748-8832, as your correspondence is most welcome. Additionally, the physical location of the single location of International Journal-Cancer can be found at the coordinates 40.737232,-74.028714 as well as the street address 111 River St in Hoboken, New Jersey 07030.

For its online presence, you may visit International Journal-Cancer’s website at wiley.com and engage with its social media outlets through on Twitter and on Facebook.